Accra, March 7, GNA – Professor Isaac Odame, the Medical Director, Global Sickle Cell Disease Network, says Hydroxyurea drugs have proven to be effective for the
ACCRA, Ghana, November 11, 2019 /3BL Media/– Today, the Government of Ghana announced the availability of hydroxyurea for the treatment of people with sickle cell
The Government on
The Impact of Hydroxyurea Use on Cognitive Functioning of Children with Sickle Cell Disease in Ghana | Blood | American Society of Hematology
The major causes of morbidity and
Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of sickle cell disease (SCD) as it improves treatment outcomes
Hydroxyurea (HU) is a well-known genotoxic agent whose biological impact on living organisms has been known for almost a century []
17 A recent study demonstrated its safety Hydroxyurea (HU), or hydroxycarbamide, is a hydroxylated analogue of urea (Fig
Hydroxyurea is a commonly used medicine for patients with SCD in developed countries, and was approved by the Food and Drugs
Purpose: One of the main treatments for the life threatening sickle cell disease (SCD) is the generic drug hydroxyurea, which reduces complications associated with SCD and therefore increases quality of life while prolonging life expectancy
Hydroxyurea is a well-tolerated oral drug that has been in use for several decades
[…] Hydroxyurea is a commonly used medicine for patients with SCD in developed countries, and is approved for use in both adults and children
This followed a five-year Memorandum of Understanding (MoU) signed between Ghana and Novartis, an
Hydroxyurea is a commonly used medicine for patients with SCD in developed countries, and is approved for use in both adults and children
Although, HIV viral load is reduced by antiretroviral therapy (ART), the number of people on ART continues to rise in Ghana
Hydroxyurea, (a medication for reducing anemia in sickle cell patients), has become the most accessible Sickle Cell solution on the Ghanaian market, aiding an exponential